High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia
Carmine Gazzaruso, Nicoletta Carlo Stella, Giuseppe Mariani, Carlo Nai, Adriana Coppola, Daniela Naldani, Pietro Gallotti
Topics & Concepts
MedicineRheumatologyLupus anticoagulantAnti-nuclear antibodyPneumoniaInternal medicineSystemic lupus erythematosusCoronavirus disease 2019 (COVID-19)AntibodyImmunologyAutoantibodyInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research